1. Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. (9th July 2018) Authors: Hansen, A R; Massard, C; Ott, P A; Haas, N B; Lopez, J S; Ejadi, S; Wallmark, J M; Keam, B; Delord, J -P; Aggarwal, R; Gould, M; Yang, P; Keefe, S M; Piha-Paul, S A Journal: Annals of oncology Issue: Volume 29:Number 8(2018) Page Start: 1807 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗